查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1847890

细菌和病毒检体采集市场（按检体类型、产品、技术、最终用户和分销管道划分）—2025-2032年全球预测

Bacterial & Viral Specimen Collection Market by Specimen Type, Product, Technology, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，细菌和病毒检体采集市场将成长至 503.5 亿美元，复合年增长率为 10.22%。

主要市场统计数据
基准年 2024 231亿美元
预计年份：2025年 254.5亿美元
预测年份：2032年 503.5亿美元
复合年增长率 (%) 10.22%

了解在不断变化的临床环境中，检体采集检体和营运弹性如何成为诊断准确性和公共卫生紧急准备的关键所在。

细菌和病毒检检体采集是现代临床诊断、感染疾病监测和治疗监测的基石。高检体完整性可确保检测结果的准确性，支持及时的临床决策，并为应对新疫情的公共卫生反应奠定基础。近年来，随着实验室技术的进步和临床工作流程的演变，在日益分散的医疗环境中，能够维持检体完整性的采集系统的重要性日益凸显。

随着诊断方法的多样化，检体采集正从单一的物流功能转变为端到端诊断品质的关键环节。临床实验室、医院、门诊部和诊断中心都在寻求能够可靠支援分子检测、培养方法和就地检验的系统。同时，製造商和采购团队面临着许多复杂的要求，包括与自动化分析仪的兼容性、运输介质的稳定性、拭子材料的性能以及低温运输和环境稳定性等方面的限制。

这种做法将检体采集置于更广泛的诊断生态系统中，该系统优先考虑检体品质、可追溯性和工作流程效率。以下章节将分析正在重塑产品设计、供应链和区域需求模式的各种因素，为理解产品开发、采购和营运韧性方面的策略选择奠定全面基础。

检验了技术、临床和供应链力量融合所带来的影响，这种融合正在重新定义人们对检体体采集系统和诊断操作的预期。

技术创新、监管环境的改善以及医疗服务模式的演进正在改变细菌和病毒检体采集的模式。拭子材料、运输培养基配方以及检体相容型采集管的进步，为在各种临床环境中保存核酸和活体微生物创造了新的可能性。这些技术发展与自动化技术的改进相辅相成，简化了工作流程，并降低了高通量实验室的分析前变异性。

同时，检测方式向照护现场（POC​​）、免下车采集点和居家采样等场所的分散化，也带来了新的设计要求，包括易用性、常温下检体稳定性以及面向非临床用户的详尽操作指南。对分子诊断日益增长的依赖，推动了对能够防止核酸降解并最大限度减少抑制性污染物的运输培养基的需求。为此，製造商正优先考虑与诊断平台的交叉相容性，检验在传统临床样本和新型自采集检体中的表现。

在商业层面，随着数位化采购管道的成熟以及经销商拓展服务范围，涵盖低温运输物流和最后一公里履约，分销模式正在改变。环境永续性也逐渐成为营运重点，推动着材料和包装领域的创新。在整个价值链中，这些因素正在汇聚，重新定义产品蓝图、采购标准和品质保证实务。

分析近期关税措施如何重塑检体采集组件的采购经济、供应链本地化奖励以及供应商策略。

2025年针对特定进口医疗产品实施的新关税，为检体采集供应链和采购经济带来了显着的曲折点。关税带来的成本压力在那些大量依赖海外采购的组件中最为明显，例如专用拭子纤维、聚合物采集管以及运输培养基中使用的特殊试剂。这些成本的增加正在影响医院、实验室和诊断中心的采购决策，进一步加剧了营运预算和采购週期的现有压力。

为此，相关人员采取了多种适应策略。一些製造商加快了生产能力的本地化进程，以减轻跨境课税的影响并缩短前置作业时间。另一些製造商则透过在临床可接受的情况下替代原材料或追求设计效率来优化材料清单，从而降低对进口的依赖。经销商和直销团队重新评估了定价模式和服务组合，以在维持终端用户交货时间竞争力的同时保障利润。在临床实验室和大型医院系统中，采购团队增加了供应商多元化程度，并签订了长期合同，以抵御价格波动并确保库存缓衝。

除了直接的成本影响外，关税也影响了战略投资选择。如今，在自动化基础设施的资本投资、库存持有政策以及供应商资格认证时间表等方面的决策，都纳入了贸易政策风险评估这一新的考量。虽然这些调整在短期内增加了复杂性，但也为国内供应商和契约製造製造商扩大产能创造了机会，并为最终用户协商整合服务协议提供了契机，从而降低检体生命週期内的总成本影响。

将检体类型、产品架构、技术平台、终端用户需求和分销管道转化为可行的产品和商业优先事项。

对细分市场的深入理解对于使产品设计和商业策略与临床需求保持一致至关重要。从血液、尿液和伤口采集的细菌检体与从血液、鼻咽拭子和唾液采集的病毒检体相比，在无菌条件、容器和运输培养基方面有着不同的需求。每种检体基质都存在独特的稳定性挑战和分析前变异性，必须针对目标诊断方法进行验证。

产品层面的细分进一步明确了预期性能。采集试剂套件整合了多种组件，以确保采样安全且可追溯。采集管有真空和非真空两种形式，必须与下游自动化和离心工作流程相容。拭子设计有棉质、绒毛和泡沫等多种类型，会影响检体的吸收和释放动力学，进而影响分析灵敏度。转运培养基配方分为细菌转运培养基和病毒转运培养基，每种培养基都经过最佳化，可在特定的温度和时限内维持细菌活性和核酸完整性。

自动化系统可提高吞吐量并减少分析前误差，而手动方法则可在低容量或分散式环境中保持灵活性。终端用户细分决定了采购偏好和采购量动态。诊所和诊断中心通常优先考虑经济高效、易于使用且适用于照护现场的解决方案。医院则要求与集中式实验室自动化系统相容，并具备强大的可追溯性。实验室重视批次处理的兼容性、检验资料和供应的连续性。分销管道的选择——直销、分销商或线上管道——决定了交货时间、服务水准和价格透明度，并影响製造商如何建立商业伙伴关係和售后服务。

绘製出各地区的管理体制、生产能力和临床基础设施如何影响产品开发重点和分销模式的图谱。

区域动态将在产品设计、监管策略和分销模式的优先排序中发挥关键作用。在美洲，强大的实验室网路和对分子诊断的大量投资，使得高性能运输培养基、多功能拭子和自动化相容的采血管的需求持续旺盛。大型医院系统的采购週期通常集中化，允许数量协商，但也需要大量的检验资料才能确保长期合约。供应链韧性和国内製造业是该地区政策和私人投资的重点领域。

欧洲、中东和非洲的市场格局各不相同。欧洲部分地区的法规十分严格，要求提供全面的技术文件和合格评定，而其他地区则优先考虑价格和易用性，以应对诊断获取方面更广泛的挑战。分销网络也存在差异，成功往往取决于是否拥有能够管理低温运输物流和监管申报的本地合作伙伴。在该地区，灵活的产品组合和在地化的培训资源对于打入市场策略大有裨益。

亚太地区持续保持成长和创新中心的地位，大型中心实验室迅速采用自动化技术，照护现场和区域检测基础设施也不断扩展。该地区部分地区的生产能力为全球供应链提供支持，同时多个市场的监管管道日益精简，从而加快了产品上市速度。在整个全部区域，与诊断平台的互通性、在当地气候条件下有效的稳定性以及符合当地文化的采集方法都是产品开发和开发方法中的优先事项。

识别领导企业为赢得检体采集市场所采取的策略性倡议，这些倡议结合了产品创新、製造敏捷性和可服务的商业化。

检体采集领域的领导者和创新挑战者正朝着一系列平行策略重点迈进，以期在整个诊断价值链中获取价值。垂直整合仍然是一种极具吸引力的策略。能够掌控上游原料采购、内部培养基配方和委託製造的公司，可以享受更严格的品管和更短的前置作业时间。在无法实现垂直整合的情况下，与试剂和诊断平台供应商建立策略联盟和共同开发契约，可以统一资格认证要求，并加快检验流程。

研发投入主要集中在拭子材料科学、常温运输培养基的稳定化学配方、兼顾自动化相容性和生物安全性的管路设计。一些市场参与企业正优先考虑跨多个地区的监管申报，将临床性能数据与完善的生产品质系统相结合，以推动产品在医院和参考实验室的广泛应用。在商业性，各公司正在拓展服务型产品，包括提供包含培训的检验套件、为分散式实验室提供虚拟支援以及建立物流伙伴关係以确保温控配送。

竞争优势取决于创新速度、与诊断平台的有效互通性以及快速扩大生产规模以满足突发需求的能力。那些能够保持严谨的供应链风险管理、积极与监管机构沟通并提供以客户为中心的技术支援的企业，将赢得临床检测采购方的长期信任。

为确保临床应用和业务永续营运，提出切实可行的建议，以协调产品开发、供应链弹性、监管沟通和商业模式。

产业领导者应采取多维度策略，兼顾产品绩效、供应链韧性、监管合规性和客户体验。优先进行设计检验，证明其与自动化分析仪和手动工作流程的兼容性，可降低医院、实验室和分散式检查机构的采用门槛。同样重要的是，要投资收集运输培养基和收穫成分在实际温度和运输条件下的可靠稳定性数据，以最大限度地减少分析前变异性。

为降低贸易和供应风险，製造商和买家应考虑筹资策略多元化，并为特种纤维和聚合物等关键零件建立双重采购安排。在经济可行的情况下，与本地生产商或区域契约製造製造商合作可以缩短前置作业时间，并降低跨境关税的影响。商务团队应为大型医疗保健系统制定灵活的合约方案，将数量承诺与库存和交付服务水准保证相结合。

在操作层面，扩大照护现场和本地采集的技术支援和培训可以减少人为错误并提高检体品质。製造商还可以探索附加价值服务，例如提供具有清晰说明的已验证采集套件、用于监管链的数位追踪以及整合物流解决方案。最后，将永续性目标融入产品设计和包装，与日益重视环境影响的采购政策相契合，而与监管机构进行积极的沟通则有助于产品在多区域推广应用。

解释如何透过结合主要相关人员访谈、实地观察和二手资料三角验证来支撑研究结果及其可信度。

本报告的研究结合了结构化的初步研究和严谨的二次检验，以确保研究结果是基于实证证据和实际操作情况。初步研究包括对临床实验室主任、采购负责人、医院供应链经理和产品开发专家的深入访谈，这些访谈提供了关于检体处理挑战、验证预期和采购决策驱动因素的第一手资料。对检体采集工作流程的人类学观察补充了访谈数据，突显了照护现场和社区采集点面临的实际限制。

二次分析参考了同侪审查文献、监管指导文件以及与检体采集材料和运输培养基相关的技术标准。供应链图谱分析识别了与单一来源组件和物流瓶颈相关的薄弱环节，并透过与实验室性能数据的交叉检验，证实了产品设计选择对实际应用的影响。整个分析过程中均采用了资料三角测量法，以协调不同的观点，并确保定性见解与已记录的操作实践一致。

透过记录资料纳入标准、对访谈主题进行透明编码，以及在适用情况下与领域专家进行迭代检验，确保了分析的严谨性。因此，建议策略着重于适应性和对实施情况的短期监测。在所有关键环节中，均遵守了有关保密和知情同意的资讯来源标准。

总结产品、供应链和监管策略的协调一致对于维持诊断信心和检体采集营运韧性至关重要的原因。

研究结果共同证明，检体采集不仅是后勤支援的必要环节，更是提升诊断效能的关键策略因素。拭子材料、运输培养基化学成分和试管设计的进步，以及自动化程度的提高，正在提升分析前检测的可靠性，并使不同医疗机构的诊断能力得到更广泛的应用。然而，不断变化的贸易政策、供应链集中度以及区域监管差异，都带来了特定的营运风险，需要製造商、经销商和大型机构采购商积极采取措施加以规避。

成功的策略包括：使产品设计与检验的临床工作流程相符；调整筹资策略以降低交易风险；以及使市售产品与医院、实验室和分散式检查机构的采购实际情况相符。那些整合可靠检验数据、投资于生产灵活性并提供全面技术支援的机构，最能确保供应的连续性并满足日益增长的性能期望。未来需要产品开发、法规规划和供应链管理部门协同行动，以确保检体采集系统能持续支援精准诊断和稳健的医疗服务。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合先进的分子运输载体，以提高病毒检体在远距运输过程中的稳定性
  • 实施自动化检体采集和处理流程可降低污染风险并提高细菌诊断的通量。
  • 为了支援分散式检查，对具有即时灭活功能的照护现场分子病毒采集套件的需求日益增长。
  • 创新常温病毒运输培养基配方，消除资源匮乏地区对低温运输的依赖
  • 微生物保存系统获得监管部门核准，以确保检体在下一代定序应用中的活性

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按检体类型分類的细菌和病毒检体采集市场

  • 细菌
    • 血
    • 尿
    • 刮痕
  • 病毒
    • 血
    • 鼻咽拭子
    • 唾液

第九章 细菌和病毒检体采集市场​​（按产品划分）

  • 收集套件
  • 收集管
    • 非真空管
    • 真空管
  • 拭子
    • 拭子
    • 羊群拭子
    • 泡棉棉籤
  • 运输介质
    • 细菌转运培养基
    • 病毒运输载体

第十章 按技术分類的细菌和病毒检体采集市场

  • 自动的
  • 手动的

第十一章 按最终用户分類的细菌和病毒检体采集市场

  • 诊所
  • 诊断中心
  • 医院
  • 研究所

第十二章 按分销管道分類的细菌和病毒检体采集市场

  • 直销
  • 经销商
  • 线上销售

第十三章 各地区细菌和病毒检体采集市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的细菌和病毒检体采集市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国细菌与病毒检体采集市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Merck KGaA
    • Roche Holding AG
    • bioMerieux SA
    • QIAGEN NV
    • Copan Diagnostics Inc.
    • Puritan Medical Products Company, LLC
    • Greiner Bio-One International GmbH
Product Code: MRR-FB6C9E792A02

The Bacterial & Viral Specimen Collection Market is projected to grow by USD 50.35 billion at a CAGR of 10.22% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 23.10 billion
Estimated Year [2025] USD 25.45 billion
Forecast Year [2032] USD 50.35 billion
CAGR (%) 10.22%

Understanding how specimen collection quality and operational resilience are becoming central to diagnostic accuracy and public health preparedness in evolving clinical environments

Bacterial and viral specimen collection is a foundational pillar of modern clinical diagnostics, infectious disease surveillance, and therapeutic monitoring. High-integrity specimen collection ensures accurate laboratory results, supports timely clinical decision-making, and underpins public health responses to emerging outbreaks. Over recent years, the interplay between advancing laboratory technologies and evolving clinical workflows has heightened the importance of collection systems that preserve specimen integrity across increasingly decentralized care settings.

As diagnostic modalities have diversified, specimen collection has shifted from a narrow logistics function to a critical component of end-to-end diagnostic quality. Clinical laboratories, hospitals, outpatient clinics, and diagnostic centers demand systems that reliably support molecular assays, culture-based methods, and point-of-care testing. Concurrently, manufacturers and procurement teams face complex requirements around compatibility with automated analyzers, stability of transport media, swab material performance, and cold-chain or ambient-stability constraints.

This introduction situates specimen collection within a broader diagnostic ecosystem that prioritizes sample quality, traceability, and workflow efficiency. The following sections analyze the drivers reshaping product design, supply chains, and regional demand patterns, providing a comprehensive foundation for understanding strategic choices in product development, procurement, and operational resilience.

Examining the converging technological, clinical, and supply chain forces that are redefining specimen collection systems and operational expectations for diagnostics

The landscape for bacterial and viral specimen collection is experiencing transformative shifts driven by technological innovation, regulatory refinement, and evolving care delivery models. Advances in swab materials, transport media formulations, and specimen-compatible collection tubes have created new possibilities for preserving nucleic acids and viable organisms across diverse clinical contexts. These technical developments are complemented by improvements in automation, which streamline workflows in high-throughput laboratories and reduce pre-analytical variability.

Simultaneously, decentralization of testing to point-of-care settings, drive-through collection sites, and at-home sampling has introduced fresh design imperatives: ease of use, sample stability at ambient temperatures, and robust instructions for non-clinical users. The increasing reliance on molecular diagnostics amplifies the need for transport media that prevent nucleic acid degradation and minimize inhibitory contaminants. In response, manufacturers are prioritizing cross-compatibility with diagnostic platforms and validating performance across both traditional clinical matrices and newer self-collected specimens.

On the commercial front, distribution models are shifting as digital procurement channels mature and distributors expand service offerings to include cold-chain logistics and last-mile fulfillment. Environmental sustainability is also emerging as an operational priority, prompting innovation in materials and packaging. Collectively, these forces are redefining product roadmaps, procurement criteria, and quality assurance practices across the specimen collection value chain.

Analyzing how recent tariff policies have reshaped procurement economics, supply chain localization incentives, and supplier strategies for specimen collection components

The introduction of new tariff measures in 2025 targeting certain imported medical goods has created a tangible inflection point for specimen collection supply chains and procurement economics. Tariff-induced cost pressures are most pronounced for components that are heavily sourced internationally, including specialized swab fibers, polymer collection tubes, and niche reagents used in transport media. These incremental costs feed into procurement decisions across hospitals, laboratories, and diagnostic centers, compounding existing pressures on operational budgets and procurement cycles.

In response, stakeholders have pursued multiple adaptation strategies. Some manufacturers accelerated localization of manufacturing capacity to reduce exposure to cross-border levies and to shorten lead times. Others optimized bill-of-materials, substituting raw materials where clinically acceptable and pursuing design efficiencies that lower import dependence. Distributors and direct sales teams recalibrated pricing models and service bundles to preserve margins while maintaining competitive delivery timelines for end users. For clinical laboratories and large hospital systems, procurement teams intensified supplier diversification and long-term contracting to manage price volatility and secure inventory buffers.

Beyond immediate cost impacts, tariffs have affected strategic investment choices. Decisions about capital investment in automation infrastructure, inventory carrying policies, and supplier qualification timelines now incorporate a new layer of trade-policy risk assessment. While these adjustments increase near-term complexity, they have also catalyzed opportunities for domestic suppliers and contract manufacturers to scale capacity and for end users to negotiate integrated service agreements that mitigate total cost impacts across the specimen lifecycle.

Translating specimen type, product architecture, technology platforms, end-user requirements, and distribution pathways into actionable product and commercial priorities

A granular understanding of segmentation is essential to align product design and commercial strategies with clinical needs. Specimen types influence both material selection and logistics: bacterial specimens originating from blood, urine, and wound sources impose different sterility, container, and transport media requirements than viral specimens collected from blood, nasopharyngeal swabs, or saliva. Each specimen matrix presents distinct stability challenges and pre-analytical variables that must be validated against intended diagnostic methods.

Product-level segmentation further delineates performance expectations. Collection kits integrate multiple components to ensure safe, traceable sampling; collection tubes-available in both vacuum and nonvacuum formats-must be compatible with downstream automation and centrifugation workflows. Swab design choices among cotton, flocked, and foam variants affect sample uptake and release kinetics, which in turn influence analytical sensitivity. Transport media formulations bifurcate into bacterial and viral transport media, each optimized to maintain viability or nucleic acid integrity under specified temperature and time windows.

Technology segmentation underscores operational trade-offs: automated systems enhance throughput and reduce pre-analytical errors, while manual approaches retain flexibility for low-volume or decentralized settings. End-user segmentation drives procurement preferences and volume dynamics. Clinics and diagnostic centers often prioritize cost-effective, easy-to-use solutions suited to point-of-care contexts; hospitals demand compatibility with centralized laboratory automation and robust traceability; laboratories value batch processing compatibility, validation data, and supply continuity. Distribution choices-whether direct sales, distributors, or online channels-shape time-to-delivery, service levels, and pricing transparency, and they influence how manufacturers structure commercial partnerships and after-sales support.

Mapping how regional regulatory regimes, manufacturing capacity, and clinical infrastructure are shaping product development priorities and distribution models worldwide

Regional dynamics play a decisive role in how product design, regulatory strategy, and distribution models are prioritized. In the Americas, robust laboratory networks and significant investment in molecular diagnostics create consistent demand for high-performance transport media, swab diversity, and automated-compatible collection tubes. Procurement cycles in large hospital systems are often centralized, enabling volume negotiations but also requiring extensive validation data to secure long-term contracts. Supply chain resilience and domestic manufacturing remain focal areas for policy and private-sector investment in this region.

The Europe, Middle East & Africa region presents a heterogeneous landscape. Regulatory stringency across parts of Europe demands comprehensive technical documentation and conformity assessments, whereas other parts of the region prioritize affordability and ease of use to address wider diagnostic access challenges. Distribution networks vary widely, and success often depends on local partnerships that can manage cold-chain logistics and regulatory submissions. Market entry strategies in this region benefit from adaptable product configurations and regionally tailored training resources.

Asia-Pacific continues to be a growth and innovation hub, with rapid adoption of automation in large centralized laboratories alongside expanding point-of-care and community testing infrastructure. Manufacturing capacity in parts of this region supports global supply chains, while regulatory pathways in several markets have become more streamlined, enabling faster product introductions. Across regions, interoperability with diagnostic platforms, validated stability profiles under local climatic conditions, and culturally appropriate collection instructions are recurring priorities that inform product development and go-to-market approaches.

Identifying strategic moves by leading organizations that combine product innovation, manufacturing agility, and service-enabled commercialization to win in specimen collection

Leading firms and innovative challengers in the specimen collection space are pursuing a set of parallel strategic priorities to capture value across the diagnostic value chain. Vertical integration remains a compelling approach: companies that control upstream raw material sourcing, in-house media formulation, and contracted manufacturing achieve tighter quality control and shorter lead times. Where vertical integration is not feasible, strategic alliances and co-development agreements with reagent and diagnostic platform providers help align compatibility requirements and accelerate validation pathways.

Investment in research and development is concentrated on materials science for swabs, stabilizing chemistries for ambient-temperature transport media, and tube designs that balance automation compatibility with biosafety. Several market participants have prioritized regulatory submissions across multiple geographies, coupling clinical performance data with robust manufacturing quality systems to facilitate broader adoption by hospitals and reference laboratories. Commercially, firms are expanding service-oriented offerings-such as validated kits bundled with training, virtual support for decentralized testing sites, and logistics partnerships to ensure temperature-controlled distribution.

Competitive differentiation increasingly rests on speed of innovation, validated interoperability with diagnostic platforms, and the ability to scale manufacturing rapidly in response to episodic demand. Organizations that maintain disciplined supply chain risk management, proactive regulatory engagement, and customer-centric technical support stand to gain sustained trust among clinical and laboratory buyers.

Actionable recommendations for aligning product development, supply resilience, regulatory engagement, and commercial models to secure clinical adoption and operational continuity

Industry leaders should adopt a multi-dimensional strategy that addresses product performance, supply chain resilience, regulatory alignment, and customer experience. Prioritizing design validation that demonstrates compatibility with both automated analyzers and manual workflows will reduce barriers to adoption across hospitals, laboratories, and decentralized testing sites. Equally important is investing in robust stability data for transport media and collection components under real-world temperature and transit conditions to minimize pre-analytical variability.

To mitigate trade-policy and supply risk, manufacturers and buyers should consider diversifying sourcing strategies and establishing dual-sourcing arrangements for critical components like specialized fibers and polymers. Where economically viable, localizing production or partnering with regional contract manufacturers can shorten lead times and reduce exposure to cross-border tariffs. Commercial teams should structure flexible contracting options for large health systems, combining volume commitments with service-level guarantees for inventory and delivery.

Operationally, expanding technical support and training for point-of-care and community collection reduces user error and improves specimen quality. Manufacturers can also explore value-added services such as validated collection kits that include clear instructions, digital tracking for chain-of-custody, and integrated logistics solutions. Finally, embedding sustainability goals into product design and packaging will resonate with procurement policies that increasingly incorporate environmental impact considerations, while careful engagement with regulatory bodies will expedite multi-region product introductions.

Describing the combination of primary stakeholder interviews, field observations, and secondary data triangulation that underpins the research findings and their reliability

The research underpinning this report combines structured primary investigation with rigorous secondary validation to ensure findings are grounded in empirical evidence and operational realities. Primary inputs included in-depth interviews with clinical laboratory directors, procurement leaders, hospital supply chain managers, and product development specialists, which provided first-hand accounts of specimen handling challenges, validation expectations, and procurement decision drivers. Ethnographic observations of sample collection workflows supplemented interview data to highlight practical constraints faced by point-of-care and community collection settings.

Secondary analysis reviewed peer-reviewed literature, regulatory guidance documents, and technical standards relevant to specimen collection materials and transport media. Supply chain mapping identified vulnerabilities related to single-source components and logistic chokepoints, while cross-validation against laboratory performance data confirmed the real-world implications of product design choices. Data triangulation methods were applied throughout to reconcile differing perspectives and to ensure consistency between qualitative insights and documented operational practices.

Where applicable, analytic rigor was maintained through documented inclusion criteria for sources, transparent coding of interview themes, and iterative validation sessions with subject-matter experts. Limitations include the dynamic nature of trade policy and episodic demand spikes, which can alter operational conditions rapidly; consequently, recommended strategies emphasize adaptability and near-term monitoring of policy developments. Ethical standards for confidentiality and informed consent were upheld across all primary engagements.

Synthesizing why coordinated product, supply chain, and regulatory strategies are essential to sustain diagnostic reliability and operational resilience in specimen collection

The collective findings underscore that specimen collection is a strategic enabler of diagnostic performance, not merely a logistical necessity. Advances in swab materials, transport media chemistry, and tube design, paired with greater automation uptake, are improving pre-analytical reliability and enabling broader diagnostic capability in diverse care settings. However, evolving trade policies, supply chain concentration, and regional regulatory variability create tangible operational risk that demands proactive mitigation by manufacturers, distributors, and large institutional buyers.

Successful strategies converge around alignment: aligning product designs to validated clinical workflows, aligning sourcing strategies to reduce trade exposure, and aligning commercial offerings to the procurement realities of hospitals, laboratories, and decentralized testing sites. Organizations that integrate robust validation data, invest in manufacturing flexibility, and provide comprehensive technical support will be best positioned to maintain continuity of supply and to meet heightened performance expectations. The path forward calls for coordinated action across product development, regulatory planning, and supply chain management to ensure specimen collection systems continue to support accurate diagnostics and resilient healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of advanced molecular transport media for enhanced viral specimen stability during long distance shipments
  • 5.2. Adoption of automated specimen collection and processing workflows to reduce contamination risk and increase throughput for bacterial diagnostics
  • 5.3. Rising demand for point-of-care molecular viral collection kits with immediate inactivation to support decentralized testing
  • 5.4. Innovations in ambient temperature viral transport media formulations to eliminate cold chain dependence in low-resource settings
  • 5.5. Regulatory approval of microbial preservation systems ensuring specimen viability for next-generation sequencing applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bacterial & Viral Specimen Collection Market, by Specimen Type

  • 8.1. Bacterial
    • 8.1.1. Blood
    • 8.1.2. Urine
    • 8.1.3. Wound
  • 8.2. Viral
    • 8.2.1. Blood
    • 8.2.2. Nasopharyngeal Swab
    • 8.2.3. Saliva

9. Bacterial & Viral Specimen Collection Market, by Product

  • 9.1. Collection Kit
  • 9.2. Collection Tube
    • 9.2.1. Nonvacuum Tube
    • 9.2.2. Vacuum Tube
  • 9.3. Swab
    • 9.3.1. Cotton Swab
    • 9.3.2. Flocked Swab
    • 9.3.3. Foam Swab
  • 9.4. Transport Media
    • 9.4.1. Bacterial Transport Media
    • 9.4.2. Viral Transport Media

10. Bacterial & Viral Specimen Collection Market, by Technology

  • 10.1. Automated
  • 10.2. Manual

11. Bacterial & Viral Specimen Collection Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Laboratories

12. Bacterial & Viral Specimen Collection Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Bacterial & Viral Specimen Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bacterial & Viral Specimen Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bacterial & Viral Specimen Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Danaher Corporation
    • 16.3.4. Merck KGaA
    • 16.3.5. Roche Holding AG
    • 16.3.6. bioMerieux SA
    • 16.3.7. QIAGEN N.V.
    • 16.3.8. Copan Diagnostics Inc.
    • 16.3.9. Puritan Medical Products Company, LLC
    • 16.3.10. Greiner Bio-One International GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BACTERIAL &